Anthony Parker
Vermogen: 148 937 $ op 31-08-2026
Vermogen: 148 937 $ op 31-08-2026
Mr. Anthony M.
Parker is a Chairman at Argonaute RNA Ltd. and a Partner at Beagle Partners LLP.
He is on the Board of Directors at Allergy Therapeutics Plc, Bristol Bluegreen Ltd., Cbderma Technology Ltd., Inverpharma Ltd., Las Lilas Ltd. and Rosemont Wildwall Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2025 | 1.925.000 ( 0,03% ) | 148 937 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Directeur/Bestuurslid | 06-12-2022 |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Algemeen Directeur | 01-01-2004 |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Oprichter | 01-01-2015 |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Directeur/Bestuurslid | - |
Cbderma Technology Ltd. | Directeur/Bestuurslid | - |
Inverpharma Ltd. | Directeur/Bestuurslid | - |
Las Lilas Ltd. | Directeur/Bestuurslid | - |
Rosemont Wildwall Ltd. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Allergy Therapeutics Plc
Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Finance |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Commercial Services |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Electronic Technology |
Cbderma Technology Ltd. | |
Inverpharma Ltd. | |
Las Lilas Ltd. | |
Rosemont Wildwall Ltd. |
Kies jouw editie
Alle financiële informatie op nationaal niveau